Online Media Kit


January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »


November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »


July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »


July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

July 26, 2020 | Chronache di Scienza (Italy)

Anello vaginale per ridurre il rischio di infezione da HIV

This is the 11th medicine recommended by EMA under EU Medicines for all. More »

July 26, 2020 | Capital FM (Kenya)

New Vaginal Ring To Reduce Risk Of HIV Infection In Africa

The Dapivirine Vaginal Ring is an option for the prevention of HIV infection that women can control and use discreetly in case they cannot use or do not have access to oral PrEP. More »

July 26, 2020 | Bhekisisa (South Africa)

One step closer to protecting yourself from HIV with a vaginal ring

The EMA gave a positive opinion on the dapivirine vaginal ring, which was also tested in South Africa, for use by women ages 18 and older in emerging economies to reduce their risk of HIV infection... More »

July 25, 2020 | The Pharma Letter

Bumper activity at EMA/CHMP July meeting

The CHMP adopted a positive opinion for Dapivirine Vaginal Ring (dapivirine) used to reduce the risk of infection with HIV-1, in combination with safer sex practices when oral PrEP is not used,... More »

July 25, 2020 | The Independent (Uganda)

Dapivirine vaginal ring gets nod for HIV prevention among women

A vaginal ring that has been undergoing trials has been given approval by the EMA to be used as an HIV prevention method among women who have tested negative. More »